Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RIB43A domain with coiled-coils protein 2 (RIBC2) is a cytoskeletal protein classified as a microtubule inner protein (MIP), found as part of the dynein-decorated doublet microtubules in the cilia axoneme, where it plays a structural role in motile cilia and flagella[5][7]. It is implicated in flagellated sperm motility by contributing to the organization and stability of axonemal microtubules[5][7]. The function appears to be structural rather than catalytic or signaling, and while essential for proper axoneme function, there are no well-established drug interactions, biomarker roles, or disease associations for RIBC2[5][7][3]. RIBC2 is encoded by the RIBC2 gene (HGNC:13241, NCBI Gene:26150, Ensembl:ENSG00000128408) located on human chromosome 22[4][5]. It has several alternative names based on earlier gene annotations and paralogous relationships[5][3]. At present, the biological and medical literature does not support a direct relevance of RIBC2 as a drug target, clinical biomarker, or cause of human disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RIB43A domain with coiled-coils protein 2 (RIBC2).